Flavored Vapes Reduce Smoking Rates Among Adults
Published on March 3, 2023
|Title||Associations Between E-cigarette Use and E-cigarette Flavors With Cigarette Smoking Quit Attempts and Quit Success: Evidence From a U.S. Large, Nationally Representative 2018–2019 Survey|
|Authors||Yoonseo Mok, MPH, Jihyoun Jeon, PhD, David T Levy, PhD, Rafael Meza, PhD|
|Citation||Nicotine & Tobacco Research, Volume 25, Issue 3, March 2023, Pages 541–552|
“Flavored e-cigarette use is associated with increased quit attempts and increased quit success among smokers in the US”
The study investigated the relationship between e-cigarette use and smoking cessation outcomes, particularly the impact of vape flavors on quitting attempts and success.
The study found that e-cigarette use is positively associated with making smoking quit attempts and quit success. Moreover, flavored e-cigarettes, especially those with menthol or mint, were found to increase the likelihood of successfully quitting smoking. This research provides insight into the potential for e-cigarettes to help individuals quit smoking, and highlights the need to consider the impact of e-cigarette flavors on cessation outcomes.
- E-cigarette use is linked to increased chances of smoking cessation, as vape users are more likely to attempt to quit smoking and succeed in quitting.
- Vapers who use flavored e-cigarettes, especially menthol or mint, are more likely to quit smoking successfully.
- E-cigarette users who use non-tobacco flavors have higher odds of quitting smoking compared to those who exclusively use non-flavored or tobacco-flavored e-cigarettes.
- Users of menthol or mint vape flavors had slightly higher odds of success at quitting than users of other non tobacco vape flavors.
- The study’s findings suggest that e-cigarettes, especially menthol or mint-flavored ones, could help people who currently smoke quit, even if other vape flavors associated with youth use were removed from the market.
[CHART COMING SOON]
|Data Source||Nicotine & Tobacco Research, Volume 25, Issue 3, March 2023, Pages 541–552|
|Funding Source||Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health (NIH) and FDA Center for Tobacco Products (CTP) under Award Number U54CA229974. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration.|